MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.brachy.2025.04.006

Медицинская библиотека · Brachytherapy · 2025

Evaluation of the dosimetric impact and safety of MucoUp as a spacer in gynecologic brachytherapy.

Okuma Kae, Yoshiba Akane, Okamoto Hiroyuki, Inaba Koji, Kaneda Tomoya, Kashihara Tairo, Nakatani Kyohei, Takahashi Kana, Sakuramachi Madoka, Nagao Ayaka, Nakayama Yuko, Igaki Hiroshi

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Gynecologic brachytherapy (BT) is an essential component of definitive radiation therapy, but excessive radiation exposure to organs at risk (OARs) remains a major concern. MucoUp, a hyaluronic acid-based spacer, has been introduced to physically separate the high-risk clinical target volume (HR-CTV) from adjacent OARs. However, its clinical feasibility and dosimetric impact remain underexplored.

OBJECTIVE

This study aimed to evaluate the dosimetric impact and clinical feasibility of MucoUp in high-dose-rate (HDR) gynecologic BT.

METHODS

A retrospective analysis was conducted on 5 patients with gynecologic malignancies who underwent HDR BT with and without MucoUp injection. Dosimetric parameters, including HR-CTV D90 and OAR D2cc (bladder, rectum), were compared between sessions with and without MucoUp. Spacer volume retention was assessed using pre- and post-treatment CT scans.

RESULTS

MucoUp injection resulted in a significant reduction in rectal D2cc (7.19 Gy vs. 6.73 Gy, p = 0.043), while maintaining HR-CTV dose coverage (D90: 8.82 Gy vs. 9.15 Gy, p = 0.043). A nonsignificant reduction in bladder D2cc was observed (7.51 Gy vs. 7.16 Gy, p = 0.34). Spacer volume retention remained stable throughout treatment. No procedural complications or acute toxicity were observed.

CONCLUSION

This study suggests that MucoUp is a promising spacer for gynecologic BT, effectively reducing rectal dose while preserving HR-CTV coverage. Given its high stability and safety, MucoUp may serve as an alternative to existing spacer materials. Further large-scale and long-term studies are warranted to evaluate its impact on late toxicities.

Для цитирования: Okuma Kae, Yoshiba Akane, Okamoto Hiroyuki, Inaba Koji, Kaneda Tomoya, Kashihara Tairo, Nakatani Kyohei, Takahashi Kana, Sakuramachi Madoka, Nagao Ayaka, Nakayama Yuko, Igaki Hiroshi. Evaluation of the dosimetric impact and safety of MucoUp as a spacer in gynecologic brachytherapy.. Brachytherapy. 2025. DOI: 10.1016/j.brachy.2025.04.006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.